YH Zhang, DD Luo, SB Wan, XJ Qu - Pharmacological Research, 2020 - Elsevier
In this study, S1PR2 was reckoned as a brand-new GPCR target for designing inhibitors to
reverse 5-FU resistance. Herein a series of pyrrolidine pyrazoles as the S1PR2 inhibitors …